SOTIO Biotech
Czech Republic - PragueBiotechnology
Focus: SOTIO Biotech is a biotechnology company headquartered in Prague, Czech Republic, specializing in active cellular immunotherapy for oncology applications. The company operates in the pre-revenue to early-stage biotech segment focused on developing novel cancer immunotherapies.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About SOTIO Biotech
AI assessmentNot HiringNo open roles listed right now. Follow SOTIO Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Nanrilkefusp alfa
Thyroid CancerClinical Trials (1)
NCT04234113Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Phase 1Help build intelligence for SOTIO Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.